SCHEMBL17875972

SCHEMBL17875972

O=S1(=O)Cc2cc(-c3cc(-c4ccccc4)nc(-c4ccccc4)c3)ccc2-c2cc(-n3c4ccccc4c4ccccc43)ccc2C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPT P10636 3/20 0.36
HPGD P15428 3/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
DHODH Q02127 3/20 0.35
AHR P35869 1/20 0.32
ATM Q13315 1/20 0.31
LMNA P02545 3/20 0.31
NPC1 O15118 1/20 0.31
HCRTR1 O43613 1/20 0.31
GAA P10253 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
ACACA Q13085 1/20 0.31
PDE10A Q9Y233 1/20 0.30
HSP90AA1 P07900 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875913 0.96 KDM4E (0.36) KDM4EL3MBTL1ALDH1A1MAPTHPGD
SCHEMBL17875986 0.95 KDM4E (0.38) KDM4EL3MBTL1ALDH1A1MAPTHPGD
SCHEMBL17875954 0.91 TDP2 (0.35) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL17877870 0.90 ABCB1 (0.35) KDM4EL3MBTL1ALDH1A1MAPTHPGD
SCHEMBL17875923 0.87 ABCB1 (0.35) KDM4EL3MBTL1ALDH1A1MAPTHPGD
SCHEMBL17875922 0.86 ATM (0.35) KDM4EL3MBTL1MAPTATMLMNA
SCHEMBL17877844 0.85 MYC (0.36) KDM4EL3MBTL1ALDH1A1MAPTHPGD
SCHEMBL17875984 0.85 L3MBTL1 (0.37) KDM4EL3MBTL1ALDH1A1MAPTATM
SCHEMBL17875977 0.84 MEN1 (0.39) KDM4EL3MBTL1ALDH1A1MAPTHPGD
SCHEMBL17875869 0.84 KDM4E (0.40) KDM4EL3MBTL1ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 KDM4E 3120/4885L3MBTL1 768/4885ALDH1A1 1061/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 KDM4E 3120/4885L3MBTL1 768/4885ALDH1A1 1061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.